drugset / Trial / NCT01555151

Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma

NCT01555151

Phase 2 Completed 739 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the efficacy, safety and pharmacokinetics of Mometasone furoate delivered via Concept1 device or Twisthaler® device in adult and adolescent patients with persistent asthma.

Timeline

Start
2012-07
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 80 ug Inhaled
Subject Mometasone furoate Other / unclassified 200 ug Inhaled
Subject Mometasone furoate Other / unclassified 320 ug Inhaled
Subject Mometasone furoate Other / unclassified 800 ug Inhaled

Indications